About
The McDevitt lab is focused on the engineering of innovative technologies to translate the morphogenic potential of stem cells as models of development and disease, as well to develop cellular and molecular therapies aimed to treat degenerative diseases and traumatic injuries. Learn more about the research.
Our technologies are applicable to a wide variety of diseases, including cardiovascular, orthopedic and neurological disorders. Specific diseases that we can apply our research to include treatments for diabetes, chronic wounds, and autoimmune disorders. The McDevitt lab's work also has other applications, including wound healing, irritable bowel syndrome, epilepsy and bone regeneration. Learn more about specific applications.
News
Francis Collins, Director of NIH, Visits Georgia Universities
McDevitt presents lab's work.
June, 2013
Review Highlighted in Trends Limited Edition
Trends in Biotechnology review published in Trends limited edition "Perspectives in Stem Cell Research."
June, 2013
Chromatin Meets Its Organizers
Commentary on "Architectural Protein Subclasses Shape 3D Organization of Genomes during Lineage Commitment" publication.
June, 2013
µSHEAR Techonology Featured on Francis Collins's Blog
iPS cells have a ‘stickiness’ that allows them to adhere to surfaces inside the sorting chip with different strengths than other cells.
May, 2013
Stem Cell Isolation: Differential Stickiness
µSHEAR technology featured in Nature Materials News & Views.
May, 2013
